CVR: 41466162
XcelCyte A/S was a Danish company of the type Aktieselskab based in Aarhus C, founded in 2020. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Hans Henrik Højrup Bondegaard. The company is owned by LILLE FREDERIKSLUND INVEST ApS and EEP CO-Investment Ltd.. In 2024, the company reported a gross profit of DKK -16,526 and a net result of DKK -19,254 compared with DKK -36,278 the year before. Equity amounted to DKK -18,918.
Selskabets formål er at forske i, udvikle, producere og markedsføre medicinske, farmaceutiske, gen- og celleterapi, samt tekniske produkter og service ydelser samt anden dertil knyttet virksomhed efter bestyrelsens nærmere bestemmelse.
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
On December 2, 2025, XcelCyte A/S entered liquidation.
XcelCyte A/S has published its annual report for 2024. Gross profit came to DKK -16,526, and the net result was DKK -19,254.
XcelCyte A/S has published its annual report for 2023. Gross profit came to DKK -20,700, and the net result was DKK -36,278.
XcelCyte A/S has published its annual report for 2022. Gross profit came to DKK -77,818, and the net result was DKK -157,336.
As of January 24, 2023, Jesper Brinkmann has left the board of directors of XcelCyte A/S.
As of January 24, 2023, Per Falholt has left the board of directors of XcelCyte A/S.
As of January 24, 2023, David Carl Christian von Kauffmann has left the board of directors of XcelCyte A/S.
As of January 24, 2023, Hans Henrik Højrup Bondegaard is registered as liquidator of XcelCyte A/S.
As of January 24, 2023, Christian Gunni Pedersen has stepped down as director of XcelCyte A/S.
On January 24, 2023, XcelCyte A/S entered liquidation.
XcelCyte A/S has published its annual report for 2021. Gross profit came to DKK -2,214,502, and the net result was DKK -2,058,059.
As of May 16, 2022, BDO Holding VII, statsautoriseret revisionsaktieselskab has stepped down as auditor of XcelCyte A/S.
XcelCyte A/S has published its interim report for the period June 26, 2020 – December 31, 2020.
As of November 24, 2020, BDO Holding VII, statsautoriseret revisionsaktieselskab has been appointed auditor of XcelCyte A/S.
As of November 24, 2020, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of XcelCyte A/S.
As of June 26, 2020, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of XcelCyte A/S.
As of June 26, 2020, Jesper Brinkmann has joined the board of directors of XcelCyte A/S.
As of June 26, 2020, Per Falholt has joined the board of directors of XcelCyte A/S.
As of June 26, 2020, David Carl Christian von Kauffmann has joined the board of directors of XcelCyte A/S.
As of June 26, 2020, Christian Gunni Pedersen is registered as director of XcelCyte A/S.
As of June 26, 2020, LILLE FREDERIKSLUND INVEST ApS is registered as an owner of XcelCyte A/S with an ownership share of 33%.
As of June 26, 2020, is registered as an owner of XcelCyte A/S with an ownership share of 33%.
XcelCyte A/S was founded on June 26, 2020.
Companies in the same industry and area
CVR 44067196
CVR 28104871
CVR 44150069
CVR 43206338
CVR 42656550
companydata.dk